【安诺优达递表港交所,正式申报港股IPO】3月25日,安诺优达基因科技股份有限公司递表港交所,正式申报港股IPO。据招股书显示,安诺优达是一家以分子诊断为基础的IVD医疗器械,以及多组学的生命科学研究服务公司,实控人为比亚迪创始人之一的夏佐全。

金融界
26 Mar
3月25日,安诺优达基因科技股份有限公司递表港交所,正式申报港股IPO。据招股书显示,安诺优达是一家以分子诊断为基础的IVD医疗器械,以及多组学的生命科学研究服务公司,实控人为比亚迪创始人之一的夏佐全。

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10